Long-term efficacy of a double-blind, placebo-controlled, randomized study for repetitive sphenopalatine blockade with bupivacaine vs. saline with the Tx360 device for treatment of chronic migraine
Autores: Cady RK, Saper J, Dexter K, Cady RJ, Manley HR
-
2015
A double-blind, placebo-controlled study of repetitive transnasal sphenopalatine ganglion blockade with tx360(®) as acute treatment for chronic migraine
Autores: Cady R, Saper J, Dexter K, Manley HR
-
2014
